Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage
- Status
- UNKNOWN
- Phase
- PHASE2
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiosurgery Plus Bevacizumab in Glioblastoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2